title: Merck pays $1bn penalty in relation to promotion of rofecoxib.
authors: Janice Hopkins
authors: JH
authors: Tanne
mesh_terms: D052246:Cyclooxygenase 2 Inhibitors / Q000191:economics*; D004345:Drug Industry / Q000191:economics* / Q000331:legislation & jurisprudence; D006801:Humans; D007783:Lactones / Q000191:economics*; D008389:Marketing of Health Services / Q000191:economics* / Q000331:legislation & jurisprudence; D028743:Professional Misconduct / Q000331:legislation & jurisprudence*; D013450:Sulfones / Q000191:economics*; D014481:United States
chemical_list: D052246:Cyclooxygenase 2 Inhibitors; D007783:Lactones; D013450:Sulfones; C116926:rofecoxib